Psychedelics get a hearing at FDA
The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.npr.org — the content belongs to NPR Health.
